Tumors with concomitant IGF1R/EGFR FISH+ were observed in 34 cases (30.1%).     ///    "Patients with concomitant IGF1R/EGFR FISH+/IHC+ had a worse DFS and overall survival (p = 0.005 and p = 0.01, respectively). "    ///    "The multivariate model confirmed that IGF1R/EGFR FISH+/IHC+ (hazard ratio (HR), 4.08. "    ///    "IGF1R/EGFR FISH+ and IGF1R/EGFR IHC+ were significantly associated (?(2) = 4.02, p = 0.04). "    ///    "Patients with IGF1R/EGFR FISH+ and IGF1R/EGFR IHC+ were associated with shorter disease-free survival (DFS) (p = 0.05 and p = 0.05, respectively). "    ///    IGF1R/EGFR FISH+/IHC+ is an independent negative prognostic factor for DFS in early NSCLC.     ///    IGF1R/EGFR FISH+ correlates with IGF1R/EGFR IHC+.     ///    Tumors with concomitant IGF1R/EGFR IHC+ were detected in 31 (24.8%) patients. 